C ardiovascular manifestations are a frequent finding in hyperthyroidism and hypothyroidism. It has been debated whether these alterations are the consequence solely of increased cardiac work load or an intrinsic property of thyroid hormones. Today, there is clear evidence for direct effects of these hormones on the myocardium in addition to indirect ones. In this review, we focus on the cardiovascular manifestations of thyroid dysfunction. We first briefly discuss the three potential mechanisms by which thyroid hormones might exert their cardiovascular actions: 1) by direct effects at the cellular level, 2) by interacting with the sympathetic nervous system, and 3) through alterations of the peripheral circulation and energy metabolism. Then, the consequences of such thyroid hormone effects on some particular aspects of cardiovascular function are examined. Finally, the mechanisms that may lead to the rare event of heart failure in patients with thyroid disease in the absence of preexisting heart disease are evoked. Apart from their nuclear receptor-mediated effect, thyroid hormones also have been shown to activate extranuclear sites. This concept is based on the observation that T3 increases cellular amino acid and sugar uptake in the presence of a protein-synthesis inhibitor.5,6 However, these observations and their physiological relevance remain controversial.2 Finally, T3 also may alter plasma membrane function. Segal7 has reported facilitation of rapid calcium uptake by rat heart slices after addition of physiological concentration of T3 to the media. This effect was directly proportional to T3 concentration, thyroid hormone specific, and independent of extracellular calcium concentration. This suggests a rapid plasma membrane-mediated action of thyroid hormones with calcium as the second messenger.7
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Direct Effects of Thyroid Hormones
at the Cellular Level The active thyroid hormone T3 exerts its effects mainly at the cellular level through activation of mRNA coding for specific proteins via binding to specific nuclear receptors.1 These nuclear receptors belong to the c-erbA supergene family.1 So far, four receptors have been described. Three of them -a,-, Al-, and f2-receptors -have a high binding affinity for T3, whereas the a2-receptor has no T3-binding domain and is likely to function as a T3 antagonist. In the rat, the three T3-binding receptors have a specific tissue distribution.
The Preceptors are ubiquitous in all tissues. The 813-receptors appear to be regulated by various expression factors, including thyroid hormones, and are expressed in thyroid hormone-responsive tissues such as liver, kidney, brain, and heart. The $-receptor is particular because it is expressed only in the pituitary and hypothalamus.1,2 It is likely that the distribution of these receptors in humans is similar, if not identical, to that found in the rat, even though the human p2-receptor has not been cloned.
The effects of T3 are complex and multiple, some being stimulant, others inhibitory, and many of them occurring in concert with other hormones and factors. In the myocardium of some animal species, T3 can change the spectrum of myosin heavy chain and Na+,K+-ATPase isoforms; in the human, it may act mainly by stimulating the sarcoplasmic calcium ATPase, an enzyme that is involved in diastolic relaxation. Other well-known determinants of cardiac function, ANF and the cytosolic malic enzyme, also are partly controlled by T3.3,4 Apart from their nuclear receptor-mediated effect, thyroid hormones also have been shown to activate extranuclear sites. This concept is based on the observation that T3 increases cellular amino acid and sugar uptake in the presence of a protein-synthesis inhibitor. 5, 6 However, these observations and their physiological relevance remain controversial.2 Finally, T3 also may alter plasma membrane function. Segal7 has reported facilitation of rapid calcium uptake by rat heart slices after addition of physiological concentration of T3 to the media. This effect was directly proportional to T3 concentration, thyroid hormone specific, and independent of extracellular calcium concentration. This suggests a rapid plasma membrane-mediated action of thyroid hormones with calcium as the second messenger. These findings were confirmed in intact dogs32 and in humans33 using measurements of systolic time intervals, cardiac output, and oxygen consumption. In humans, administration of reserpine to deplete cardiac norepinephrine stores did not alter the effect of thyroid hormones on contractility. Taken together, these findmyocardial contractility that are independent of catecholamines.
In 1982, Forfar et al studied in hypothyroid34 and hyperthyroid patients35 the effects of exercise and 18-adrenergic blockade on left ventricular function assessed by radionuclide ventriculography. Resting left ventricular ejection fraction was reduced in hypothyroid patients and increased after replacement therapy. Conversely, resting left ventricular ejection fraction was increased in hyperthyroid patients and decreased to normal values in the euthyroid state. In hypothyroidism, left ventricular ejection fraction responses to both exercise and ,B-adrenergic blockade with propranolol were similar before and after thyroid hormone substitution. Furthermore, propranolol did not alter the exerciseinduced change in left ventricular ejection fraction in hyperthyroidism. These data appear to favor the concept of a direct rather than a sympathetically mediated effect of hyperthyroidism or hypothyroidism on myocardial function. Yet, it cannot be infered from these data that thyroid hormones have a direct effect on the heart rather than on the peripheral circulation. Indeed, Wieshammer et al,36 studying nine athyreotic patients, have reported decreased cardiac performance that was primarily related to alterations in loading conditions and exercise heart rate. In this model of short-term hypothyroidism, ejection fraction, systolic pressure/volume relation, and pulmonary capillary wedge pressure were similar at rest and during exercise in both hypothyroid and euthyroid states. 36 Echocardiography studies37 found a correlation between thyroid hormone levels and velocity of circumferential fiber shortening. In hyperthyroid patients studied before and after treatment, Feldman et a138 found a strong correlation between left ventricular contractility and serum thyroid hormone levels. These findings provide additional evidence for a direct inotropic action of thyroid hormones since the observed changes in left ventricular ejection fraction were not associated with alterations of ventricular loading conditions. Left ventricular end-diastolic dimension and end-systolic wall stress remained unchanged after treatment for hyperthyroidism.38 However, contractile reserve may be decreased in hyperthyroid patients. This concept has emerged from the observation that left ventricular ejection fraction, although elevated at rest in these patients, does not increase further during exercise. 35 The biochemical mechanisms responsible for the intrinsic effect of thyroid hormones on cardiac contractile properties are mediated by specific nuclear receptor proteins. In concert with other nuclear factors, these receptors control thyroid hormone-responsive genes, in particular, the myosin isoenzymes. In hypothyroidism, myosin isoenzymes are predominantly present as the slowly contracting 13 The effects of thyroid function on venous compliance and blood volume are still elusive. In a study by Gay et al,56 compared with controls, hyperthyroid rats displayed an increase in mean circulatory filling pressure, no change in blood volume, and a decrease in venous compliance, whereas hypothyroid rats showed a decrease in mean circulatory filling pressure and blood volume but no change in venous compliance. The same group of investigators, in hyperthyroid calves, also reported increases in mean circulatory filling pressure and decreases in venous compliance, but in this model, they were associated with increased blood volume.57'58 Increases in mean circulatory filling pressure in thyrotoxic calves probably were not caused by sympathetic stimulation because sympathetic and ganglionic blockade had no effect on filling pressure. 57 Studies in humans performed early this century have provided evidence that blood volume is increased in hyperthyrodism and decreased in hypothyrodism.59 There are no data about the effect of thyroid hormones on venous compliance in humans.
In contrast to venous compliance and blood volume, several studies examined the effects of thyroid hormones on peripheral resistance. Theilen and Wilson60 studied the effects of phenylephrine infusion on cardiac index in thyrotoxic patients and in controls pretreated with atropine. They found that during phenylephrine infusion, only hyperthyroid patients showed a decrease in cardiac output, suggesting that the increased cardiac output at baseline was due, at least in part, to peripheral vasodilatation. Such vasodilatation may be related to heat production and relative tissue hypoxia caused by increased tissue metabolism. This interpretation would be consistant with the observation in hypothyroid patients of an increased peripheral resistance and a low cardiac output, the latter being directly related to decreased oxygen consumption.61
Thyroid dysfunction also may alter blood pressure. Hyperthyroidism, generally has only minor effects on mean arterial pressure because increases in systolic blood pressure, caused by increased stroke volume, are offset by decreases in diastolic blood pressure, due to peripheral vasodilatation. 62 Conversely hypothyroidism has been reported to be associated with increases in diastolic blood pressure.63 '64 For example, in a study of 40 hyperthyroid patients overtreatment that resulted in hypothyroidism was associated with an increase in diastolic blood pressure that was reversible when thyroid function returned to normal.63 In a survey of 688 consecutive hypertensive outpatients, 3.6% were found to be hypothyroid,54 and in this subset, diastolic blood pressure fell significantly after adequate thyroid replacement suggesting a cause-and-effect relation. Hormonal profiling revealed that more than half of these hypothyroid hypertensive patients displayed low plasma renin activity, a finding also reported by others.65,66 Low angiotensin levels have also been reported in hypothyroidism. 67 These observations suggest that renin, angiotensin, and aldosterone play a minor role in this form of hypertension.62 In contrast, sympathetic activation that has been consistently reported in hypothyroid patients1168,69 may play a role in sustaining high diastolic blood pressure. However, the above-mentioned alterations in renin-angiotensin and aldosterone may contribute to the expanded plasma volume of hyperthyroidism and the opposite effects in hypothyroidism.
Prohormone atrial natriuretic peptides and atrial natriuretic factor (ANF) are decreased in hypothyroid patients, whereas patients with hyperthyroidism display a marked increase in the levels of these peptides.70 This increase may be due to a direct effect of T3 on ANF mRNA transcription and ANF synthesis as shown in vitro.71 Nonetheless, ANF does not appear to play a key role in systemic blood pressure control.72 Finally, vasopressin may contribute to the increased peripheral resistance seen in hypothyroidism because plasma levels have been reported to be mildly increased73 and to return to normal after replacement therapy. 74 Chronotropic Effect The well-known positive chronotropic effect of thyroid hormones is not found in all models of hyperthyroidism and does not appear to parallel their positive inotropic effect. Marcus et al,75 using an isolated rat heart model, found no significant increase in heart rate in L-thyroxine-treated hearts compared with controls but a significant difference in contractility. This study suggests that in vivo factors, such as the interaction with the autonomic nervous system, act synergically to produce a hyperthyroid-related tachycardia.75 However, other groups have come to a different conclusion, suggesting a direct chronotropic effect of T4. In their double-heart model discussed earlier, Klein and Hong found that T4 increased similarly the heart rate of the denervated infrarenal and the innervated in situ hearts. 44 In another study, Valente et a176 found that heart rate in both thyroidectomized and hypophysectomized rats decreased similarly and proportionally to thyroid hormone levels but independently of thyroid stimulating hormone levels. In the same study, the effects of thyroidectomy and chemical sympathectomy on the heart were compared in two groups of rats. The group with thyroidectomy had a significantly slower heart rate than the group with sympathectomy. However, both groups responded with a similar increase in heart rate after treatment with T3.76 These data suggest that thyroid hormones have a direct chronotropic effect. This interpretation is supported by three lines of evidence. First, in vitro studies using preparations of rabbit sinoatrial node and atrial fibers found that thyroid hormones decrease the duration of the repolarization phase of the membrane action potential and increase the rate of the diastolic depolarization and therefore the rate of contraction.76-78 Second, studies using an isolated, perfused heart model found that hearts from animals with experimental hyperthyroidism show increased heart rates and shorter mean effective refractory periods79 than hearts from euthyroid animals.
Finally, in isolated hearts from euthyroid animals, addition of T3 to the perfusate stimulates heart rate and shortens refractory period. The mechanism by which thyroid hormones induce these electrophysiological changes is still elusive but may be related in part to their effects on sodium pump density80 and enhancement of Na+ and K' permeability.8' In humans, chronotropic effects of thyroid hormones have been assessed using 24-hour ambulatory ECG recordings. Hyperthyroid patients show an increase in heart rate throughout sleeping and wake hours,82 whereas in hypothyroid patients a decrease in basal, average, and maximal heart rates was found even though most of them were not bradycardic at rest.83 After treatment, heart rates in both groups returned to normal. 82 Pathophysiological consequences of such direct and indirect thyroid hormone effects include increased myocardial contractility and relaxation that may be related to stimulation by T3 of specific myocardial enzymes. However, when left ventricular hypertrophy occurs in association with hyperthyroidism, it may be related to either direct thyroid hormone-induced stimulation of myocardial protein synthesis or to thyrotoxicosis-induced increases in cardiac work load. Although hyperthyroidism generally has little or no effect on mean arterial blood pressure, hypothyroidism is often associated with increases in diastolic blood pressure that are reversible after hormone substitution and may be mediated in part by sympathetic activation. Moreover, there is increasing evidence that thyroid hormones have direct chronotropic effect on the heart that are independent of the sympathetic nervous system. Finally, thyroid hormones may trigger arrhythmias mostly at the level of the atria, and there is some evidence that tissue hypothyroidism may increase the fibrillation threshold of the ventricles. However, there are no clear data in humans indicating that hypothyroidism confers a protection against ventricular or atrial arrhythmias.
